プラスミン処理ヒト免疫グロブリンの血中消失半減期について

DOI Web Site PubMed

書誌事項

タイトル別名
  • The Biological Half-life of Plasmin-treated Human Immunoglobulin in Blood
  • プラスミン ショリ ヒト メンエキ グロブリン ノ ケッチュウ ショウシツ ハ

この論文をさがす

抄録

Few reports on the half-life of gammaglobulin in various diseases have been published. The authors measured its half-life by 131I-labelled plasmin-treated human immunoglobulin in various disorders, especially in blood and liver diseases.<br>The blood samples were drawn from a case or two cases of AML, AMoL, CML in blastic crisis, aplastic anemia, SLE, cancer of the lung and gall bladder and liver cirrhosis.<br>The half-life of immunoglobulin was 5.1, 6.9 and 5.8 days in the patients with AML, AMoL and CML in blastic crisis, respectively. The half-life tended to be shorter in cases of leukemia complicated by infections and/or with many leukemic cells. The half-life of immunoglobulin in two cases of aplastic anemia was 5.3 and 6.2 days. The half-life was shorter in the febrile cases. The half-life was 6.7 and 7.1 days in two patients suffering from cirrhosis of the liver, and 10.5 days in the case of severe liver impairment in association with cancer of the bile-duct.<br>These results suggested that the immunoglobulin half-life in blood depends on the disease and became shorter in patients under severe conditions with complicated serious infections. These changes seem to be influenced by the metabolism of the immunoglobulin.

収録刊行物

  • 臨床血液

    臨床血液 21 (11), 1637-1645, 1980

    一般社団法人 日本血液学会

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ